You are about to leave the Clinical Value website now.

Cancel

HCV

31 May 2023

APASL 2023 Taiwan Congress Report

Catch up on the highlights of APASL 2023 with this congress report, covering session on hepatitis B, hepatitis C, hepatocellular carcinoma, and fatty liver disease.

READ MORE
14 March 2023

Impact of PIVKA-II in diagnosis of hepatocellular carcinoma

This study was designed to investigate the potential role of PIVKA-II as a diagnostic, non-invasive marker for HCC at its early stages and to assess its…

READ MORE
9 December 2022

Liver Disease in Asia Pacific: Insights from Prof Pierce Chow

In this Q&A, Prof Pierce Chow of the National Cancer Centre Singapore discusses the epidemiology of liver disease in Asia Pacific; key considerations around the clinical…

READ MORE
9 December 2022

Tackling HCV in Punjab: local experts share strategies for success

Punjab is one of Pakistan’s largest provinces and has a particularly high HCV prevalence rate of roughly 9%, compared to 5.4% for Pakistan’s total population. Hear…

READ MORE
9 December 2022

Pakistan’s national HCV elimination programme: insights from Dr Huma Qureshi

In 2019, Pakistan announced a nationwide programme to scale up HCV prevention, testing and treatment. Hear from gastroenterologist Dr Huma Qureshi, a key figure in Pakistan’s…

READ MORE
9 December 2022

Hepatitis C: the patient journey from screening to diagnosis and treatment

An estimated 71 million people around the world are chronically infected with hepatitis C virus (HCV), with a large proportion currently being undiagnosed or diagnosed late.…

READ MORE
9 December 2022

HCV screening in Egypt: key elements of a successful national screening programme

In 2018, the world’s largest HCV screening campaign was initiated in Egypt. Within 7 months following its initiation, 49.5 million people were screened; and 2.2 million…

READ MORE
9 December 2022

HCV elimination in Sindh: insights from Prof Muhammad Sadik Memon and Dr Zaigham Abbas

The province of Sindh has one of the world’s highest rates of HCV infection and bears the second highest disease burden of both HBV and HCV…

READ MORE
9 December 2022

HCV elimination in Pakistan: insights from Dr Zaigham Abbas

Pakistan has one of the world’s highest rates of HCV infection. Learn from Dr Zaigham Abbas, Head of Gastroenterology at Ziauddin University Hospital and President of…

READ MORE
9 December 2022

HCV elimination in Northern Pakistan: Prof Aamir Khan on treating patients in KPK province and the Afghan borderlands

Pakistan has one of the world’s highest rates of HCV infection. It's no surprise that their healthcare systems face mounting pressure from HCV-related conditions. Learn from…

READ MORE

Be the first to receive updates, event opportunities, and thought leadership insights.